For the year ending 2025-12-31, ALDX has $72,059,317 in assets. $27,808,927 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 70,041,254 | |||
| Marketable securities | 0 | |||
| Prepaid expenses and other current assets | 1,742,202 | |||
| Total current assets | 71,783,456 | |||
| Deferred offering costs | 0 | |||
| Right-of-use assets | 275,861 | |||
| Total assets | 72,059,317 | |||
| Accounts payable | 158,461 | |||
| Accrued expenses | 6,120,297 | |||
| Current portion of debt | 15,249,632 | |||
| Operating lease liabilities | 280,537 | |||
| Deferred collaboration revenue | 6,000,000 | |||
| Total current liabilities | 27,808,927 | |||
| Long-term debt, net of current portion | 0 | |||
| Total liabilities | 27,808,927 | |||
| Common stock, voting, 0.001 par value 150,000,000 authorized and 59,648,278 and 59,195,951 shares issued and outstanding, respectively | 60,163 | |||
| Additional paid-in capital | 528,147,480 | |||
| Accumulated other comprehensive income | 0 | |||
| Accumulated deficit | -483,957,253 | |||
| Total stockholders equity | 44,250,390 | |||
| Total liabilities and stockholders equity | 72,059,317 | |||
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)